Cita APA

Barkin, J. A., Keihanian, T., Barkin, J. S., Antequera, C. M., & Moshiree, B. (2019). Preferential usage of rifaximin for the treatment of hydrogen-positive small intestinal bacterial overgrowth.

Citación estilo Chicago

Barkin, Jodie A., Tara Keihanian, Jamie S. Barkin, Carol M. Antequera, y Baharak Moshiree. Preferential Usage of Rifaximin for the Treatment of Hydrogen-positive Small Intestinal Bacterial Overgrowth. 2019.

Cita MLA

Barkin, Jodie A., et al. Preferential Usage of Rifaximin for the Treatment of Hydrogen-positive Small Intestinal Bacterial Overgrowth. 2019.